{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:31:26Z","timestamp":1772166686375,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T00:00:00Z","timestamp":1768435200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W007002\/1"],"award-info":[{"award-number":["MR\/W007002\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diagn Progn Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Approximately one million adults in the UK are estimated to have undiagnosed type 2 diabetes mellitus (T2DM), with a further 5.1 million adults with nondiabetic hyperglycaemia (NDH) that does not meet the threshold for a diabetes diagnosis. The Leicester Risk Assessment score (LRA) and Leicester Practice Risk score (LPR) are diagnostic risk prediction models that estimate an individual\u2019s risk of undiagnosed T2DM and NDH, developed for use in community and primary care settings respectively. The LRA is also used as a prognostic model; neither model has been updated since development. This study will systematically review all applications of these models as diagnostic and prognostic tools and any published updates to evaluate their performance in different populations. This review has been registered with PROSPERO (CRD420251005841).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We will implement a citation search strategy to search Scopus, Web of Science and Google Scholar, restricted to full text, English language papers. Eligible papers will validate, update or modify either model. Data will be extracted using a form based on the Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies (CHARMS) checklist; missing information will be sought from authors or estimated from other available information where possible. Meta-analysis of predictive performance measures will be completed if sufficient data exist. Subgroup and sensitivity analyses will be used to explore between-study heterogeneity and risk-of-bias impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This review will identify studies that have implemented, modified or validated the LRA and LPR for the risk of undiagnosed T2DM and NDH in different populations. This will allow summary measures, including level of uncertainty, of model performance to be calculated, making this highly relevant to individuals and stakeholders who recommend and implement these models. Review conclusions will also inform the potential update and recalibration of the models. This will ultimately lead to improved outcomes through earlier diagnosis and management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41512-026-00219-w","type":"journal-article","created":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:22:30Z","timestamp":1768486950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Performance of the Leicester risk assessment and Leicester practice risk scores for assessing the risk of undiagnosed type 2 diabetes or prediabetes in diverse populations: protocol for a systematic review of published validations and updates"],"prefix":"10.1186","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5015-5121","authenticated-orcid":false,"given":"Louise","family":"Haddon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joie","family":"Ensor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,15]]},"reference":[{"key":"219_CR1","unstructured":"Office of National Statistics. Risk factors for pre-diabetes and undiagnosed type 2 diabetes in England - Office for National Statistics. Available from: https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/healthandsocialcare\/healthinequalities\/bulletins\/riskfactorsforprediabetesandundiagnosedtype2diabetesinengland\/2013to2019 Accessed Oct 22, 2025."},{"key":"219_CR2","unstructured":"NICE. Definition | Background information | Diabetes - type 2 | CKS | NICE. https:\/\/cks.nice.org.uk. Accessed Nov 5, 2025."},{"key":"219_CR3","unstructured":"England NHS, NHS England \u00bb NHS Diabetes Prevention Programme (NHS DPP). Available from: https:\/\/www.england.nhs.uk\/diabetes\/diabetes-prevention\/ Accessed Nov 5, 2025."},{"key":"219_CR4","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 10th edn. 2021. Available from https:\/\/idf.org\/about-diabetes\/resources. Accessed Aug 5, 2025."},{"issue":"1","key":"219_CR5","first-page":"5703652","volume":"2018","author":"R Paprott","year":"2018","unstructured":"Paprott R, Scheidt-Nave C, Heidemann C. Determinants of change in glycemic status in individuals with prediabetes: results from a nationwide cohort study in Germany. J Diabetes Res. 2018;2018(1):5703652.","journal-title":"J Diabetes Res"},{"issue":"9833","key":"219_CR6","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","volume":"379","author":"AG Tab\u00e1k","year":"2012","unstructured":"Tab\u00e1k AG, Herder C, Rathmann W, Brunner EJ, Kivim\u00e4ki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279\u201390.","journal-title":"Lancet"},{"issue":"4","key":"219_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamainternmed.2020.8774","volume":"181","author":"MR Rooney","year":"2021","unstructured":"Rooney MR, Rawlings AM, Pankow JS, Echouffo Tcheugui JB, Coresh J, Sharrett AR, et al. Risk of progression to diabetes among older adults with prediabetes. JAMA Intern Med. 2021;181(4):511\u20139.","journal-title":"JAMA Intern Med"},{"key":"219_CR8","unstructured":"Diabetes UK. Prediabetes symptoms and risk reduction. Available from: https:\/\/www.diabetes.org.uk\/about-diabetes\/type-2-diabetes\/prediabetes?gad_campaignid=15219795559&gad_source=1&gbraid=0AAAAAD4IfZWahtIkjwGReRwFL30-O2Xjz Accessed Oct 23, 2025."},{"issue":"2","key":"219_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00125-024-06315-0","volume":"68","author":"MR Rooney","year":"2024","unstructured":"Rooney MR, Wallace AS, Echouffo Tcheugui JB, Fang M, Hu J, Lutsey PL, et al. Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes. Diabetologia. 2024;68(2):357.","journal-title":"Diabetologia"},{"issue":"8","key":"219_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1111\/j.1464-5491.2010.03037.x","volume":"27","author":"LJ Gray","year":"2010","unstructured":"Gray LJ, Taub NA, Khunti K, Gardiner E, Hiles S, Webb DR, et al. The Leicester risk assessment score for detecting undiagnosed type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med. 2010;27(8):887.","journal-title":"Diabet Med"},{"key":"219_CR11","unstructured":"NICE. Type 2 diabetes: prevention in people at high risk. Public Health Guideline PH38. London: NICE. 2012 (updated 2017). Available from: https:\/\/www.nice.org.uk\/guidance\/ph38. Accessed Aug 5 2025."},{"issue":"3","key":"219_CR12","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.diabres.2014.03.018","volume":"104","author":"LJ Gray","year":"2014","unstructured":"Gray LJ, Khunti K, Wilmot EG, Yates T, Davies MJ. External validation of two diabetes risk scores in a young UK South Asian population. Diabetes Res Clin Pract. 2014;104(3):451.","journal-title":"Diabetes Res Clin Pract"},{"key":"219_CR13","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.jclinepi.2021.01.009","volume":"132","author":"M Van Smeden","year":"2021","unstructured":"Van Smeden M, Reitsma JB, Riley RD, Collins GS, Moons KG. Clinical prediction models: diagnosis versus prognosis. J Clin Epidemiol. 2021;132:142.","journal-title":"J Clin Epidemiol"},{"issue":"11","key":"219_CR14","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1111\/dme.13433","volume":"34","author":"SR Barber","year":"2017","unstructured":"Barber SR, Dhalwani NN, Davies MJ, Khunti K, Gray LJ. External National validation of the Leicester Self-Assessment score for type 2 diabetes using data from the english longitudinal study of ageing. Diabet Med. 2017;34(11):1575.","journal-title":"Diabet Med"},{"key":"219_CR15","doi-asserted-by":"crossref","unstructured":"Liu X, Littlejohns TJ, Be\u0161evi\u0107 J, Bragg F, Clifton L, Collister JA et al. Incorporating polygenic risk into the Leicester risk assessment score for 10-year risk prediction of type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2024;18(4):102996.","DOI":"10.1016\/j.dsx.2024.102996"},{"key":"219_CR16","doi-asserted-by":"crossref","unstructured":"Jenkins DA, Martin GP, Sperrin M, Riley RD, Debray TPA, Collins GS et al. Continual updating and monitoring of clinical prediction models: time for dynamic prediction systems? Diagn Progn Res. 2021;5(1).","DOI":"10.1186\/s41512-020-00090-3"},{"key":"219_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Reviews. 2015;4:1\u20139.","journal-title":"Syst Reviews"},{"key":"219_CR18","doi-asserted-by":"crossref","unstructured":"Snell KIE, Levis B, Damen JAA, Dhiman P, Debray TPA, Hooft L et al. Transparent reporting of multivariable prediction models for individual prognosis or diagnosis: checklist for systematic reviews and meta-analyses (TRIPOD-SRMA). BMJ. 2023:381.","DOI":"10.1136\/bmj-2022-073538"},{"key":"219_CR19","doi-asserted-by":"crossref","unstructured":"Moons KG, Hooft L, Williams K, Hayden JA, Damen JA, Riley RD. Implementing systematic reviews of prognosis studies in Cochrane. Cochrane Database of Systematic Reviews. 2018;(10):ED000129.","DOI":"10.1002\/14651858.ED000129"},{"key":"219_CR20","doi-asserted-by":"crossref","unstructured":"Debray TP, Damen JA, Snell KI, Ensor J, Hooft L, Reitsma JB et al. A guide to systematic review and meta-analysis of prediction model performance. BMJ. 2017;356:i6460.","DOI":"10.1136\/bmj.i6460"},{"issue":"3","key":"219_CR21","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1002\/jrsm.1635","volume":"14","author":"J Hirt","year":"2023","unstructured":"Hirt J, Nordhausen T, Appenzeller-Herzog C, Ewald H. Citation tracking for systematic literature searching: A scoping review. Res Synthesis Methods. 2023;14(3):563\u201379.","journal-title":"Res Synthesis Methods"},{"key":"219_CR22","doi-asserted-by":"crossref","unstructured":"Janssens ACJW, Gwinn M. Novel citation-based search method for scientific literature: application to meta-analyses. BMC Med Res Methodol. 2015;15(1):84.","DOI":"10.1186\/s12874-015-0077-z"},{"key":"219_CR23","unstructured":"Veritas Health Innovation 2025. Covidence systematic review software 5.0.131. Melbourne, Australia. Available at https:\/\/www.covidence.org."},{"key":"219_CR24","unstructured":"Corporation for Digital Scholarship. Zotero version 7.0.11. Available from: https:\/\/www.zotero.org"},{"issue":"10","key":"219_CR25","doi-asserted-by":"publisher","first-page":"e1001744","DOI":"10.1371\/journal.pmed.1001744","volume":"11","author":"KG Moons","year":"2014","unstructured":"Moons KG, de Groot JA, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist. PLoS Med. 2014;11(10):e1001744.","journal-title":"PLoS Med"},{"issue":"1","key":"219_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12916-019-1466-7","volume":"17","author":"B Van Calster","year":"2019","unstructured":"Van Calster B, McLernon DJ, van Smeden M, Wynants L, Steyerberg EW, Bossuyt P, et al. Calibration: the Achilles heel of predictive analytics. BMC Med. 2019;17(1):230.","journal-title":"BMC Med"},{"key":"219_CR27","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jclinepi.2015.12.005","volume":"74","author":"B Van Calster","year":"2016","unstructured":"Van Calster B, Nieboer D, Vergouwe Y, De Cock B, Pencina MJ, Steyerberg EW. A calibration hierarchy for risk models was defined: from utopia to empirical data. J Clin Epidemiol. 2016;74:167\u201376.","journal-title":"J Clin Epidemiol"},{"key":"219_CR28","unstructured":"Derezea E, Ades AE, Rogers G, Sutton AJ, Cooper NJ, Hamilton J et al. Technical Support Document 25: Evidence synthesis of diagnostic test accuracy for decision making report by the decision support unit Nov 2024. Available from: https:\/\/www.sheffield.ac.uk\/nice-dsu."},{"issue":"9","key":"219_CR29","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1177\/0962280218785504","volume":"28","author":"TP Debray","year":"2018","unstructured":"Debray TP, Damen JA, Riley RD, Snell K, Reitsma JB, Hooft L, et al. A framework for meta-analysis of prediction model studies with binary and time-to-event outcomes. Stat Methods Med Res. 2018;28(9):2768.","journal-title":"Stat Methods Med Res"},{"key":"219_CR30","unstructured":"StataCorp. 2025. Stata Statistical Software: Release 19. College Station, TX: StataCorp LLC. Available from https:\/\/www.stata.com"},{"issue":"1","key":"219_CR31","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"RF Wolff","year":"2019","unstructured":"Wolff RF, Moons KG, Riley RD, Whiting PF, Westwood M, Collins GS, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170(1):51\u20138.","journal-title":"Ann Intern Med"},{"key":"219_CR32","doi-asserted-by":"crossref","unstructured":"Riley RD, Ensor J, Snell KI, Debray TP, Altman DG, Moons KG et al. External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challenges. BMJ. 2016;22:353.","DOI":"10.1136\/bmj.i3140"},{"key":"219_CR33","doi-asserted-by":"crossref","unstructured":"Heus P, Damen JAAG, Pajouheshnia R, Scholten RJPM, Reitsma JB, Collins GS et al. Poor reporting of multivariable prediction model studies: towards a targeted implementation strategy of the TRIPOD statement. BMC Med. 2018;16(1):120.","DOI":"10.1186\/s12916-018-1099-2"},{"issue":"1","key":"219_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/jrsm.1266","volume":"9","author":"TP Debray","year":"2018","unstructured":"Debray TP, Moons KG, Riley RD. Detecting small-study effects and funnel plot asymmetry in meta\u2010analysis of survival data: a comparison of new and existing tests. Res Synthesis Methods. 2018;9(1):41\u201350.","journal-title":"Res Synthesis Methods"},{"issue":"4","key":"219_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.cmi.2022.07.019","volume":"29","author":"JAA Van Damen","year":"2022","unstructured":"Damen JAA, Moons KGM, Van Smeden M, Hooft L. How to conduct a systematic review and meta-analysis of prognostic model studies. Clin Microbiol Infect. 2022;29(4):434.","journal-title":"Clin Microbiol Infect"},{"key":"219_CR36","doi-asserted-by":"crossref","unstructured":"Inthout J, Pa J, Borm GF. The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method.\u00a0BMC Med Res Methodol. 2014;14(1):25.","DOI":"10.1186\/1471-2288-14-25"},{"key":"219_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jclinepi.2021.11.024","volume":"143","author":"FP Foroutan","year":"2021","unstructured":"Foroutan FP, Guyatt G, Trivella M, Kreuzberger N, Skoetz N, Riley RD, et al. GRADE concept paper 2: concepts for judging certainty on the calibration of prognostic models in a body of validation studies. J Clin Epidemiol. 2021;143:202.","journal-title":"J Clin Epidemiol"},{"key":"219_CR38","doi-asserted-by":"crossref","unstructured":"Foroutan F, Mayer M, Guyatt G, Riley RD, Mustafa R, Kreuzberger N et al. GRADE concept paper 8: judging the certainty of discrimination performance estimates of prognostic models in a body of validation studies. J Clin Epidemiol. 2024;170:111344.","DOI":"10.1016\/j.jclinepi.2024.111344"},{"issue":"3","key":"219_CR39","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/sim.1023","volume":"21","author":"JA Berlin","year":"2002","unstructured":"Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI. Individual patient-versus group\u2010level data meta\u2010regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med. 2002;21(3):371\u201387.","journal-title":"Stat Med"},{"issue":"5","key":"219_CR40","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1002\/sim.7141","volume":"36","author":"DL Burke","year":"2017","unstructured":"Burke DL, Ensor J, Riley RD. Meta-analysis using individual participant data: one\u2010stage and two\u2010stage approaches, and why they May differ. Stat Med. 2017;36(5):855\u201375.","journal-title":"Stat Med"},{"key":"219_CR41","doi-asserted-by":"publisher","first-page":"j5019","DOI":"10.1136\/bmj.j5019","volume":"359","author":"J Hippisley-Cox","year":"2017","unstructured":"Hippisley-Cox J, Coupland C. Development and validation of QDiabetes-2018 risk prediction algorithm to estimate future risk of type 2 diabetes: cohort study. BMJ. 2017;359:j5019.","journal-title":"BMJ"},{"key":"219_CR42","doi-asserted-by":"publisher","first-page":"b880","DOI":"10.1136\/bmj.b880","volume":"338","author":"J Hippisley-Cox","year":"2009","unstructured":"Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P. Predicting risk of type 2 diabetes in England and wales: prospective derivation and validation of QDScore. BMJ. 2009;338:b880.","journal-title":"BMJ"},{"key":"219_CR43","doi-asserted-by":"crossref","unstructured":"Wright K, Golder S, Rodriguez-Lopez R. Citation searching: a systematic review case study of multiple risk behaviour interventions. BMC medical research methodology. 2014;14(1):73.","DOI":"10.1186\/1471-2288-14-73"}],"container-title":["Diagnostic and Prognostic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41512-026-00219-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41512-026-00219-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41512-026-00219-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:23:04Z","timestamp":1768486984000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41512-026-00219-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,15]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1186\/s41512-026-00219-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7252002\/v1","asserted-by":"object"}]},"ISSN":["2397-7523"],"issn-type":[{"value":"2397-7523","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,15]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"LG and KK developed the original models.KK was Chair of the National Institute for Care and Excellence Type 2 diabetes: prevention in people at high risk Guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2"}}